Interim Provost Daniel Jaffe announced Wednesday that Samuel Poloyac will serve as the next dean of the College of Pharmacy, effective Oct. 15, in an email to the community. 

Poloyac currently serves as the associate dean for graduate and postdoctoral programs in the School of Pharmacy at the University of Pittsburgh, according to the email. He also serves as director of the Center for Clinical Pharmaceutical Sciences, director of the Small Molecule Biomarker Core Laboratory and an appointment to the Clinical and Translational Science Institute, according to the email. 

Jaffe said in the email that Poloyac’s research is focused on critical care pharmacology, specifically the role of drug metabolizing enzymes on fatty acid bioactivation and drug disposition in critically ill patients. Dean Lynn Crismon will see Poloyac through the transition and will return to the college faculty, according to the email.

“I have great confidence in a successful transition due to the strength and support of the College of Pharmacy community,” Jaffe said. “The college is highly regarded as one of the top programs of its kind in the nation and well positioned for success going forward.”